Crossmark

Chemoradiotherapy Plus High-dose-rate Intraluminal Brachytherapy Versus Chemoradiotherapy Alone in Locally Advanced Esophageal Carcinoma: A Single Center Experience with Limited Infrastructure

Crossref DOI link: https://doi.org/10.1007/s13193-025-02192-0

Published Online: 2025-01-13

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Agrawal, Aditi

Zaheer, Samreen https://orcid.org/0000-0002-9769-8593
Akram, Mohammad
License Information

Text and Data Mining valid from 2025-01-13

Version of Record valid from 2025-01-13
More Information

Article History

Received: 21 August 2024

Accepted: 2 January 2025

First Online: 13 January 2025

Declarations

:

: The author declares no conflicts of interest in the preparation of the manuscript.

Document is current

Any future updates will be listed below